This article outlines what is currently known about its dosing, mechanism, suitability, safety profile, and regulatory status
This triple mechanism distinguishes it from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GIP/GLP-1 agonist)
Limitations No dosing, administration, treatment, cosmetic, veterinary, or human-use guidance is provided
Arr recruitment at the GLP-1R leads to internalization of the receptor toward endosomal compartments, which has been proposed to impact receptor desensitization and signaling duration in preclinical models ( 18, 19 )
doi: 10.1016/S2468-2667(19)30105-7
More practically, you can kickstart stalled weight loss by adjusting your eating or physical activity habits